[{"NetIncomeLoss_2_Q2_USD":7241000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":28685000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-3266000.0,"PaymentsForRestructuring_2_Q2_USD":900000.0,"PaymentsForRestructuring_1_Q2_USD":900000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-28572000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":1917000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":304000.0,"AssetsCurrent_0_Q2_USD":343570000.0,"OtherNoncashIncomeExpense_2_Q2_USD":1933000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":22506000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":46575000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":23166000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":15047000.0,"SellingAndMarketingExpense_2_Q2_USD":97792000.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":1300000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_2_Q2_USD":17497000.0,"CommonStockSharesIssued_0_Q2_shares":19209063.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":11635000.0,"Assets_0_Q2_USD":595709000.0,"ShareBasedCompensation_2_Q2_USD":8558000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":5161000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":3839000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":-1022000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":36476000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.1,"PaymentsToAcquireBusinessesGross_2_Q2_USD":18000000.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"SellingAndMarketingExpense_1_Q2_USD":43479000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":177958000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":32912000.0,"DepreciationAndAmortization_2_Q2_USD":13269000.0,"EarningsPerShareBasic_2_Q2_USD":0.38,"EarningsPerShareBasic_1_Q2_USD":-0.96,"FinanceLeasePrincipalPayments_2_Q2_USD":124000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":19271467.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":19215392.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":4271000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":5069000.0,"AccountsReceivableNetCurrent_0_Q2_USD":67407000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-18440000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1592000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"CommonStockValue_0_Q2_USD":1921000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":100000000.0,"DepreciationAndAmortization_1_Q2_USD":6942000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":1.647,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":101918000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-6900000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":2100000.0,"RestrictedCash_0_Q2_USD":503000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-468000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":7014000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16940000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4782000.0,"OtherAssetsNoncurrent_0_Q2_USD":10026000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":172888000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3411000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":282287000.0,"Liabilities_0_Q2_USD":250664000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.095,"ResearchAndDevelopmentExpense_1_Q2_USD":8765000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":73135000.0,"OperatingIncomeLoss_1_Q2_USD":-21000000.0,"Goodwill_0_Q2_USD":82997000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-11199000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16832000.0,"InterestIncomeExpenseNet_2_Q2_USD":-1324000.0,"InterestIncomeExpenseNet_1_Q2_USD":-901000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1110000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4699000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":30094000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":7936000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":19215392.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":19149523.0,"LiabilitiesCurrent_0_Q2_USD":89596000.0,"DeferredLongTermLiabilityCharges_0_Q2_USD":1300000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":1484000.0,"AccountsPayableCurrent_0_Q2_USD":14911000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-452000.0,"LongTermDebtNoncurrent_0_Q2_USD":100000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":57527000.0,"GrossProfit_2_Q2_USD":131383000.0,"GrossProfit_1_Q2_USD":49969000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":173391000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":772000.0,"ProvisionForLoanAndLeaseLosses_2_Q2_USD":1564000.0,"OperatingLeasePayments_2_Q2_USD":2082000.0,"OtherAccruedLiabilitiesNoncurrent_0_Q2_USD":5700000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-687000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":65113000.0,"NetIncomeLoss_1_Q2_USD":-18424000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":20726000.0,"OperatingIncomeLoss_2_Q2_USD":-14146000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-227000.0,"EarningsPerShareDiluted_2_Q2_USD":0.37,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":6364000.0,"InventoryNet_0_Q2_USD":82046000.0,"RestructuringReserve_0_Q2_USD":3600000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-1184000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":595709000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4699000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8558000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":21399000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_2_Q2_USD":-227000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q2_USD":1484000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1934000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":1949000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":400000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.96,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":503000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":449000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":338000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":224000.0,"OtherLiabilitiesCurrent_0_Q2_USD":74236000.0,"StockholdersEquity_0_Q2_USD":345045000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":8560000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_Q2_USD":-227000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_1_Q2_USD":1484000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":6364000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":64103000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":102988000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-16291000.0,"CommonStockSharesOutstanding_0_Q2_shares":19209063.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":38562000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":18729000.0,"Ticker":"OFIX","CIK":"884624","name":"ORTHOFIX MEDICAL INC.","OfficialName":"Orthofix Medical Inc. Common Stock (DE)","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"666662095.0","Country":"Curacao","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]